Latest Breaking News On - Christian pangratz - Page 1 : comparemela.com

Atriva Therapeutics Announces Exclusive Letter Agreement for Reverse Takeover Transaction with Biocure Technology

Atriva Therapeutics and Canadian Biocure Technologies, Inc. entered into an exclusive letter agreement for a reverse takeover transaction. Upon successful completion of the transaction, the resulting entity will continue the business of Atriva Therapeutics. Shareholders of Atriva will receive not less than 75% of the securities of the resulting issuer, with the current shareholders of Biocure Technology holding the remainder. The transaction is subject to various terms and conditions, including

South koreaBritish columbiaChristian pangratzUlrich dauerBiocure technologyCanadian biocure technologies incBiocure technology incAtriva therapeuticsCanadian biocure technologiesTherapeutics gmbhChief executive officerAdvisory boardInterferon betaLetter agreementSuccessful completionIocure technology inc

EQS-News: Atriva Therapeutics Announces Exclusive Letter Agreement for Reverse Takeover Transaction with Biocure Technology

EQS-News: Atriva Therapeutics GmbH / Key word(s): Letter of Intent Atriva Therapeutics Announces Exclusive Letter Agreement for Reverse Takeover Transaction with Biocure Technology 18.09.2023 / 15:05 CET/CEST The issuer is solely responsible for the content of this announcement. Atriva Therapeut.

South koreaBritish columbiaUlrich dauerChristian pangratzBiocure technology incDistribution servicesCanadian biocure technologies incBiocure technologyAtriva therapeutics gmbhTherapeutics announces exclusive letter agreementReverse takeover transactionCanadian biocure technologiesChief executive officerAdvisory boardInterferon betaCorporate news

Sterna Biologicals Announces Dosing of First Patient in Phase IIa Proof-of-concept Study with SB010 in Moderate to Severe Asthma

Sterna Biologicals Announces Dosing of First Patient in Phase IIa Proof-of-concept Study with SB010 in Moderate to Severe Asthma
pittsburghstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pittsburghstar.com Daily Mail and Mail on Sunday newspapers.

Anne hennecke vera langMedizinische hochschule hannoverChristian pangratzMarion wenckerVisionhealth kataTobias welteMc servicesGmbh coGlobal initiative for asthmaGlobal initiativeChief medical officerHospital directorCoordinating investigatorUnited states wire group

sterna biologicals announces dosing of first patient in phase IIa proof-of-concept study with SB010

DGAP-News: sterna biologicals GmbH & Co. KG / Key word(s): Study/Miscellaneous14.12.2021 / 14:00 The issuer is solely responsible for the content of this announcement.STERNA BIOLOGICALS ANNOUNCES DOSING OF FIRST PATIENT IN PHASE IIA PROOF-OF-CONCEPT STUDY WITH SB010 IN MODERATE TO SEVERE ASTHMA GIANT-1 study to eva.

Anne hennecke vera langMedizinische hochschule hannoverChristian pangratzMarion wenckerVisionhealth kataTobias welteMc servicesGmbh coDistribution servicesGlobal initiative for asthmaAsthmatics notGlobal initiativeChief medical officerHospital directorCoordinating investigatorCorporate news

Sterna Biologicals Announces Dosing of First Patient in Phase IIa Proof-of-concept Study with SB010 in Moderate to Severe Asthma

Sterna Biologicals Announces Dosing of First Patient in Phase IIa Proof-of-concept Study with SB010 in Moderate to Severe Asthma
newjerseytelegraph.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newjerseytelegraph.com Daily Mail and Mail on Sunday newspapers.